Norepinephrine dysregulation may be associated with type 2 diabetes pathophysiology, showing significant correlations with glycemic control parameters in specific treatment subgroups.
Abstract Background: Type 2 diabetes is a chronic metabolic disorder characterized by high blood sugar levels (hyperglycemia) resulting from the body's reduced ability to produce or use insulin effectively. Insulin is a hormone that regulates blood sugar levels, and in type 2 diabetes, the body either does not produce enough insulin or becomes resistant to its effects. This causes a buildup of glucose in the bloodstream, which can eventually harm organs and tissues. This study was carried out on patients who attended the Diabetes and Endocrinology Specialist Center of Marjan City for Medical Education in Babil Province., all patients were diagnosed by a specialist physician. The practical side of the study was performed at the Clinical Chemistry Laboratory in the College of Medicine and College of Biotechnology, Al-Qadisiyah University. Objectives: Investigate the Correlation of Norepinephrine with some biochemical Parametric in patients with type 2 diabetes mellitus. Methods: The method used in this study Enzyme-Linked Immunosorbent Assay (ELISA). Results: In the metformin treatment group and the group not using antidiabetic treatment, there are weak associations between norepinephrine and insulin levels, but these associations are not statistically significant. In the diamicron MR treatment group, norepinephrine is significantly correlated with lower levels of fasting blood glucose and HbA1c. Conclusions: Norepinephrine dysregulation may be associated with type 2 diabetes, regardless of specific treatments, indicating a potential role of norepinephrine in the pathophysiology of the disease.
Aqeel et al. (Fri,) studied this question.